2.55Open1.80Pre Close4 Volume367 Open Interest78.00Strike Price935.00Turnover46.66%IV1.02%PremiumDec 20, 2024Expiry Date1.52Intrinsic Value100Multiplier4DDays to Expiry0.78Extrinsic Value100Contract SizeAmericanOptions Type-0.6452Delta0.0987Gamma32.20Leverage Ratio-0.1754Theta-0.0052Rho-20.78Eff Leverage0.0302Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet